Efficacy and Safety of Hybrid Epicardial and Endocardial Ablation Versus Endocardial Ablation in Patients with Persistent and Longstanding Persistent Atrial Fibrillation: a Randomised, Controlled Trial

Overview

Journal EClinicalMedicine

Specialty General Medicine

Date 2023 Jul 10

PMID 37425372

Authors

Nicolas Doll

Timo Weimar

Dariusz A Kosior

Alan Bulava

Ales Mokracek

Gerold Monnig

Jonathan Sahu

Steven Hunter

Maurits Wijffels

Bart van Putte

Norman Rub

Petr Nemec

Tomas Ostrizek

Piotr Suwalski

Affiliations

Soon will be listed here.

Abstract

Background: Endocardial catheter ablation (CA) has limited long-term benefit for persistent and longstanding persistent atrial fibrillation (PersAF/LSPAF). We hypothesized hybrid epicardial-endocardial ablation (HA) would have superior effectiveness compared to CA, including repeat (rCA), in PersAF/LSPAF.

Methods: CEASE-AF (NCT02695277) is a prospective, multi-center, randomized controlled trial. Nine hospitals in Poland, Czech Republic, Germany, United Kingdom, and the Netherlands enrolled eligible participants with symptomatic, drug refractory PersAF and left atrial diameter (LAD) > 4.0 cm or LSPAF. Randomization was 2:1 to HA or CA by an independent statistician and stratified by site. Treatment assignments were masked to the core rhythm monitoring laboratory. For HA, pulmonary veins (PV) and left posterior atrial wall were isolated with thoracoscopic epicardial ablation including left atrial appendage exclusion. Endocardial touch-up ablation was performed 91-180 days post-index procedure. For CA, endocardial PV isolation and optional substrate ablation were performed. rCA was permitted between days 91-180. Primary effectiveness was freedom from AF/atrial flutter/atrial tachycardia >30-s through 12-months absent class I/III anti-arrhythmic drugs except those not exceeding previously failed doses. It was assessed in the modified intention-to-treat (mITT) population who had the index procedure and follow-up data. Major complications were assessed in the ITT population who had the index procedure. Thirty-six month follow-up continues.

Findings: Enrollment began November 20, 2015 and ended May 22, 2020. In 154 ITT patients (102 HA; 52 CA), 75% were male, mean age was 60.7 ± 7.9 years, mean LAD was 4.7 ± 0.4 cm, and 81% had PersAF. Primary effectiveness was 71.6% (68/95) in HA versus 39.2% (20/51) in CA (absolute benefit increase: 32.4% [95% CI 14.3%-48.0%], p < 0.001). Major complications through 30-days after index procedures plus 30-days after second stage/rCA were similar (HA: 7.8% [8/102] versus CA: 5.8% [3/52], p = 0.75).

Interpretation: HA had superior effectiveness compared to CA/rCA in PersAF/LSPAF without significant procedural risk increase.

Funding: AtriCure, Inc.

Citing Articles

2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Tzeis S, Gerstenfeld E, Kalman J, Saad E, Sepehri Shamloo A, Andrade J J Arrhythm. 2024; 40(6):1217-1354.

PMID: 39669937 PMC: 11632303. DOI: 10.1002/joa3.13082.

Ablation Strategies for Persistent Atrial Fibrillation: Beyond the Pulmonary Veins.

Baqal O, Shafqat A, Kulthamrongsri N, Sanghavi N, Iyengar S, Vemulapalli H J Clin Med. 2024; 13(17).

PMID: 39274244 PMC: 11396655. DOI: 10.3390/jcm13175031.

Short- and long-term outcomes in isolated vs. hybrid thoracoscopic ablation in patients with atrial fibrillation: a systematic review and reconstructed individual patient data meta-analysis.

Aerts L, Kawczynski M, Bidar E, Luermans J, Chaldoupi S, La Meir M Europace. 2024; 26(10).

PMID: 39255332 PMC: 11448334. DOI: 10.1093/europace/euae232.

Hybrid video-assisted thoracoscopic radiofrequency ablation of recurrent ventricular tachycardia in a patient with desmoplakin cardiomyopathy.

Schoonvelde S, van Schaagen F, Hirsch A, Michels M, Yap S HeartRhythm Case Rep. 2024; 10(7):463-467.

PMID: 39129740 PMC: 11312025. DOI: 10.1016/j.hrcr.2024.04.005.

Advances in Clinical Cardiology 2023: A Summary of Key Clinical Trials.

Savage P, Cox B, Shahmohammadi M, Kelly B, Menown I Adv Ther. 2024; 41(7):2606-2634.

PMID: 38743242 PMC: 11213809. DOI: 10.1007/s12325-024-02877-y.

References

Kistler P, Chieng D, Sugumar H, Ling L, Segan L, Azzopardi S . Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial. JAMA. 2023; 329(2):127-135. PMC: 9856612. DOI: 10.1001/jama.2022.23722. View

Varzaly J, Lau D, Chapman D, Edwards J, Worthington M, Sanders P . Hybrid ablation for atrial fibrillation: A systematic review and meta-analysis. JTCVS Open. 2022; 7:141-154. PMC: 9390199. DOI: 10.1016/j.xjon.2021.07.005. View

Valderrabano M, Peterson L, Swarup V, Schurmann P, Makkar A, Doshi R . Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial. JAMA. 2020; 324(16):1620-1628. PMC: 7592031. DOI: 10.1001/jama.2020.16195. View

Shah S, Barakat A, Saliba W, Rehman K, Tarakji K, Rickard J . Recurrent Atrial Fibrillation After Initial Long-Term Ablation Success: Electrophysiological Findings and Outcomes of Repeat Ablation Procedures. Circ Arrhythm Electrophysiol. 2018; 11(4):e005785. DOI: 10.1161/CIRCEP.117.005785. View

Blackshear J, ODell J . Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996; 61(2):755-9. DOI: 10.1016/0003-4975(95)00887-X. View

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the.... Eur Heart J. 2020; 42(5):373-498. DOI: 10.1093/eurheartj/ehaa612. View

Darby A . Recurrent Atrial Fibrillation After Catheter Ablation: Considerations For Repeat Ablation And Strategies To Optimize Success. J Atr Fibrillation. 2016; 9(1):1427. PMC: 5089515. DOI: 10.4022/jafib.1427. View

Chugh S, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin E . Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2013; 129(8):837-47. PMC: 4151302. DOI: 10.1161/CIRCULATIONAHA.113.005119. View

Markman T, Hyman M, Kumareswaran R, Arkles J, Santangeli P, Schaller R . Durability of posterior wall isolation after catheter ablation among patients with recurrent atrial fibrillation. Heart Rhythm. 2020; 17(10):1740-1744. DOI: 10.1016/j.hrthm.2020.05.005. View

10.

Shrestha S, Plasseraud K, Makati K, Sood N, Killu A, Contractor T . Hybrid Convergent ablation for atrial fibrillation: A systematic review and meta-analysis. Heart Rhythm O2. 2022; 3(4):396-404. PMC: 9463711. DOI: 10.1016/j.hroo.2022.05.006. View

11.

DeLurgio D, Crossen K, Gill J, Blauth C, Oza S, Magnano A . Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation: Results of CONVERGE Clinical Trial. Circ Arrhythm Electrophysiol. 2020; 13(12):e009288. DOI: 10.1161/CIRCEP.120.009288. View

12.

Lim H, Hocini M, Dubois R, Denis A, Derval N, Zellerhoff S . Complexity and Distribution of Drivers in Relation to Duration of Persistent Atrial Fibrillation. J Am Coll Cardiol. 2017; 69(10):1257-1269. DOI: 10.1016/j.jacc.2017.01.014. View

13.

Voeller R, Bailey M, Zierer A, Lall S, Sakamoto S, Aubuchon K . Isolating the entire posterior left atrium improves surgical outcomes after the Cox maze procedure. J Thorac Cardiovasc Surg. 2008; 135(4):870-7. DOI: 10.1016/j.jtcvs.2007.10.063. View

14.

Benjamin E, Wolf P, DAgostino R, Silbershatz H, Kannel W, Levy D . Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998; 98(10):946-52. DOI: 10.1161/01.cir.98.10.946. View

15.

Verma A, Jiang C, Betts T, Chen J, Deisenhofer I, Mantovan R . Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015; 372(19):1812-22. DOI: 10.1056/NEJMoa1408288. View

16.

Gharaviri A, Bidar E, Potse M, Zeemering S, Verheule S, Pezzuto S . Epicardial Fibrosis Explains Increased Endo-Epicardial Dissociation and Epicardial Breakthroughs in Human Atrial Fibrillation. Front Physiol. 2020; 11:68. PMC: 7047215. DOI: 10.3389/fphys.2020.00068. View

17.

Thiyagarajah A, Kadhim K, Lau D, Emami M, Linz D, Khokhar K . Feasibility, Safety, and Efficacy of Posterior Wall Isolation During Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis. Circ Arrhythm Electrophysiol. 2019; 12(8):e007005. DOI: 10.1161/CIRCEP.118.007005. View

18.

Tilz R, Rillig A, Thum A, Arya A, Wohlmuth P, Metzner A . Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol. 2012; 60(19):1921-9. DOI: 10.1016/j.jacc.2012.04.060. View

19.

Al-Hijji M, Deshmukh A, Yao X, Mwangi R, Sangaralingham L, Friedman P . Trends and predictors of repeat catheter ablation for atrial fibrillation. Am Heart J. 2015; 171(1):48-55. DOI: 10.1016/j.ahj.2015.10.015. View

20.

Calkins H, Hindricks G, Cappato R, Kim Y, Saad E, Aguinaga L . 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017; 14(10):e275-e444. PMC: 6019327. DOI: 10.1016/j.hrthm.2017.05.012. View